Eli Lilly's $1.4 Billion Dollar Wrist Slap

Well, it seems the NY Times was right when they reported yesterday that Eli Lilly was about to settle the case against them for the illegal marketing of Zyprexa. There's really nothing new in the story beyond the reprehensible tactics we already knew about, but I guess what's truly shocking is how blatantly they discussed turning your problem patients into a Zyprexa zombie just to make your job easier as the nurse/physician. I do like that the article clearly demonstrates how little a $1.4 billion dollar fine is to a company like Lilly or even to the Zyprexa brand.

Eli Lilly's long-acting Zyprexa short-lived

The FDA issued a non-approvable letter for the long-acting injectable version of Zyprexa due to concerns over excessive sedation. That won't do much to stem Zyprexa's hemorrhaging market share. Guess that's just a little less milk for this cash cow.